Light therapy and supplementary riboflavin in the SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis (FALS)

✍ Scribed by Helina Moges; Olavo M. Vasconcelos; William W. Campbell; Rosemary C. Borke; Jennifer Anne McCoy; Lauren Kaczmarczyk; Ji Feng; Juanita J. Anders

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 231 KB
• Volume: 41
• Category: Article
• ISSN: 0196-8092
• DOI: 10.1002/lsm.20732

✦ Synopsis

Abstract

Background and Objective

Familial amyotrophic lateral sclerosis (FALS) is a neurodegenerative disease characterized by progressive loss of motor neurons and death. Mitochondrial dysfunction and oxidative stress play an important role in motor neuron loss in ALS. Light therapy (LT) has biomodulatory effects on mitochondria. Riboflavin improves energy efficiency in mitochondria and reduces oxidative injury. The purpose of this study was to examine the synergistic effect of LT and riboflavin on the survival of motor neurons in a mouse model of FALS.

Study Design/Materials and Methods

G93A SOD1 transgenic mice were divided into four groups: Control, Riboflavin, Light, and Riboflavin+Light (combination). Mice were treated from 51 days of age until death. A single set of LT parameters was used: 810 nm diode laser, 140‐mW output power, 1.4 cm^2^ spot area, 120 seconds treatment duration, and 12 J/cm^2^ energy density. Behavioral tests and weight monitoring were done weekly. At end stage of the disease, mice were euthanized, survival data was collected and immunohistochemistry and motor neuron counts were performed.

Results

There was no difference in survival between groups. Motor function was not significantly improved with the exception of the rotarod test which showed significant improvement in the Light group in the early stage of the disease. Immunohistochemical expression of the astrocyte marker, glial fibrilary acidic protein, was significantly reduced in the cervical and lumbar enlargements of the spinal cord as a result of LT. There was no difference in the number of motor neurons in the anterior horn of the lumbar enlargement between groups.

Conclusions

The lack of significant improvement in survival and motor performance indicates study interventions were ineffective in altering disease progression in the G93A SOD1 mice. Our findings have potential implications for the conceptual use of light to treat other neurodegenerative diseases that have been linked to mitochondrial dysfunction. Lasers Surg. Med. 41:52–59, 2009. © 2008 Wiley‐Liss, Inc.